Co-existence of chronic lymphocytic leukemia and chronic myeloid leukemia and underlying pathogenetic mechanisms

被引：0
|
作者：
Badal, Sujan [1 ]
Thapaliya, Prakash [2 ]
Oh, Kirstine [3 ]
机构：
[1] Washington State Univ, Elson S Floyd Coll Med, Providence WSU Internal Med Residency Program, Everett, WA USA
[2] Everett Clin, Providence Reg Canc Partnership Everett, Everett, WA USA
[3] Providence Reg Med Ctr, CellNetix Pathol & Labs, Everett, WA USA
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2023年 / 110卷 / 01期
关键词：
THERAPY; SUSCEPTIBILITY; MALIGNANCIES;
D O I：
10.1111/ejh.13879
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 120
页数：4
相关论文
共 50 条
  • [31] Dasatinib-responsive Chronic Lymphocytic Leukemia in a Patient Treated for Coexisting Chronic Myeloid Leukemia
    Nagao, Takayo
    Takahashi, Naoto
    Kameoka, Yoshihiro
    Noguchi, Shinsuke
    Shinohara, Yoshinori
    Ohyagi, Hideaki
    Kume, Masaaki
    Sawada, Kenichi
    INTERNAL MEDICINE, 2013, 52 (22) : 2567 - 2571
  • [32] Concomitant Venetoclax and Imatinib for Comanaging Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia: A Case Report
    Przespolewski, Eugene R.
    Baron, Jeffrey
    Kashef, Farshid
    Fu, Kai
    Sait, Sheila N. Jani
    Hernandez-Ilizaliturri, Francisco
    Thompson, James
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (02): : 102 - 107
  • [33] A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review
    Wei, Qi
    Wei, Yongqiang
    Wei, Xiaolei
    Li, Xiaofang
    Liu, Hui
    Feng, Ru
    BLOOD, 2017, 130
  • [34] MECHANISMS OF INFECTION IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    CHAPEL, HM
    BUNCH, C
    SEMINARS IN HEMATOLOGY, 1987, 24 (04) : 291 - 296
  • [35] Mechanisms of Venetoclax Resistance in Chronic Lymphocytic Leukemia
    Frenzel, Lukas P.
    Herling, Carmen D.
    Abedpour, Nima
    Weiss, Jonathan
    Mayer, Petra
    Cartolano, Maria
    Berg, Valeska
    Kutsch, Nadine
    Cramer, Paula
    Wendtner, Clemens-Martin
    Persigehl, Thorsten
    Saleh, Andreas
    Altmueller, Janine
    Nurnberg, Peter
    Pallasch, Christian
    Achter, Viktor
    Lang, Ulrich
    Eichhorst, Barbara F.
    Castiglione, Roberta
    Schaefer, Stephan C.
    Buettner, Reinhard
    Kreuzer, Karl-Anton
    Reinhardt, Hans Christian
    Hallek, Michael J.
    Peifer, Martin
    BLOOD, 2017, 130
  • [36] Drug resistance mechanisms in chronic lymphocytic leukemia
    Ribrag, V
    Massade, L
    Faussat, AM
    Dreyfus, F
    Bayle, C
    Gouyette, A
    Maire, JP
    LEUKEMIA, 1996, 10 (12) : 1944 - 1949
  • [37] Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia
    Sun, Jingnan
    Hu, Ruiping
    Han, Mengyuan
    Tan, Yehui
    Xie, Mengqing
    Gao, Sujun
    Hu, Ji-Fan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (01): : 175 - 181
  • [38] Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia
    Lernoux, Manon
    Schnekenburger, Michael
    Dicato, Mario
    Diederich, Marc
    BIOCHEMICAL PHARMACOLOGY, 2020, 173
  • [39] The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review
    Crisan, Ana Manuela
    Badelita, Sorina Nicoleta
    Jardan, Cerasela
    Vasilache, Ecaterina Didona
    Dobrea, Camelia-Marioara
    Gheorghe, Anca
    Talmaci, Rodica
    Arion, Constantin Virgiliu
    Bardas, Alexandru
    Gaman, Amelia Maria
    Coriu, Daniel
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2015, 56 (03): : 1145 - 1151
  • [40] ''Aromatogenous'' chronic myeloid leukemia? How many pathogenetic steps?
    Jankovic, GM
    Colovic, MD
    Strahinja, R
    Anagnostopoulos, A
    Andolina, M
    Janosevic, S
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 653 - 661
12345